{"schema_version":"secwatch.filing_event.v1","accession":"0001378325-26-000008","form_type":"8-K","ticker":"CV","cik":"0001378325","company_name":"CapsoVision, Inc","filed_at":"2026-03-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.950481+00:00","generated_at":"2026-05-15T08:48:15.414121+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"CapsoVision reports 15% revenue growth in FY2025; completes $14M private placement","bullets":["Q4 2025 revenue $3.9M (+13% YoY); full year $13.6M (+15% YoY) driven by higher capsule sales.","Gross margin stable at 50% Q4 and 53% full year (vs 54% prior year).","Operating expenses $9.4M Q4 (+$3.0M YoY); full year $32.7M (+$6.4M) on CMOS sensor development and public company costs.","Cash $10.1M at Dec 31, 2025; completed $14M private placement in March 2026.","Submitted FDA 510(k) for AI-assisted module; 161,000+ patients used CapsoCam Plus as of Dec 31, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001378325-26-000008","json":"https://secwatch.observer/filing/0001378325-26-000008.json","markdown":"https://secwatch.observer/filing/0001378325-26-000008.md","text":"https://secwatch.observer/filing/0001378325-26-000008.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1378325/000137832526000008/0001378325-26-000008-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1378325/000137832526000008/cv-20260326.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:48:15.414121+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"20574d94d89f976bd6fdbe860c238894ca62717b","claim":"CapsoVision, Inc reported the fourth quarter ended December 31, 2025 results: revenue $3.9 million.","evidence_excerpt":"Fourth quarter 2025 revenue was $3.9 million, a 13% increase over the fourth quarter of 2024.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1378325/000137832526000008/0001378325-26-000008-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2025"},{"label":"Revenue","value":"$3.9 million"},{"label":"Result","value":"reported results"}]},{"claim_id":"f42b9978dfa5f620c9e90d6a8f589ccb234b11a2","claim":"CapsoVision, Inc reported the full year ended December 31, 2025 results: revenue $13.6 million.","evidence_excerpt":"Full year 2025 revenue was $13.6 million, a 15% increase compared to full year 2024.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1378325/000137832526000008/0001378325-26-000008-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the full year ended December 31, 2025"},{"label":"Revenue","value":"$13.6 million"},{"label":"Result","value":"reported results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}